131 related articles for article (PubMed ID: 10744603)
1. Medical management of aldosterone-producing adenomas.
Ferriss JB
Ann Intern Med; 2000 Apr; 132(7):593-4; author reply 594. PubMed ID: 10744603
[No Abstract] [Full Text] [Related]
2. Medical management of aldosterone-producing adenomas.
Ghose RP; Hall PM; Bravo EL
Ann Intern Med; 1999 Jul; 131(2):105-8. PubMed ID: 10419425
[TBL] [Abstract][Full Text] [Related]
3. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
Wisgerhof M
J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in the surgery of aldosterone-producing tumors.
Ackerman NB; Johnson-Giannopoulos N; Winer N
Am J Surg; 1972 Dec; 124(6):774-6. PubMed ID: 4635221
[No Abstract] [Full Text] [Related]
5. Long-term medical management of aldosterone-producing adenoma.
Bornemann M
South Med J; 1990 Apr; 83(4):461-2. PubMed ID: 2108504
[TBL] [Abstract][Full Text] [Related]
6. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
7. [Corticosterone-producing adrenal tumor].
Shibata H
Nihon Rinsho; 2006 May; Suppl 1():638-40. PubMed ID: 16776236
[No Abstract] [Full Text] [Related]
8. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
Conn JW; Hinerman DL
Metabolism; 1977 Dec; 26(12):1293-307. PubMed ID: 927164
[No Abstract] [Full Text] [Related]
9. Medical management of aldosterone-producing adenomas.
Chan NN
Ann Intern Med; 2000 Apr; 132(7):594. PubMed ID: 10744604
[No Abstract] [Full Text] [Related]
10. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
[No Abstract] [Full Text] [Related]
11. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
12. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.
Yan Y; Wang C; Lu Y; Gong H; Wu Z; Ma X; Li H; Wang B; Zhang X
J Physiol Biochem; 2018 Feb; 74(1):17-24. PubMed ID: 29164516
[TBL] [Abstract][Full Text] [Related]
14. A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings.
Abdelhamid S; Lewicka S; Vecsei P; Haack D; Pahl S; Remberger K; Müller-Lobeck H; Bönhof JA; Nensel U; Röckel A
J Clin Endocrinol Metab; 1995 Mar; 80(3):737-44. PubMed ID: 7883826
[TBL] [Abstract][Full Text] [Related]
15. Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016.
Epstein M; Duprez DA
Am J Med; 2016 Jul; 129(7):661-6. PubMed ID: 26899747
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonists for heart failure.
Funder J
Expert Opin Pharmacother; 2011 Dec; 12(18):2767-9. PubMed ID: 22098225
[No Abstract] [Full Text] [Related]
17. Formation of 18-deoxy-19-noraldosterone by a human aldosterone-producing adenoma.
Takeda Y; Iki K; Miyamori I; Takeda R
Steroids; 1993 Jun; 58(6):282-5. PubMed ID: 8212075
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of aldosterone excess.
Deinum J; Riksen NP; Lenders JW
Pharmacol Ther; 2015 Oct; 154():120-33. PubMed ID: 26213109
[TBL] [Abstract][Full Text] [Related]
19. Management of aldosteronism.
Liddle GW
Am J Clin Pathol; 1970 Sep; 54(3):331-2. PubMed ID: 5507279
[No Abstract] [Full Text] [Related]
20. Obesity, sleep apnea, aldosterone, and hypertension.
Goodfriend TL
Curr Hypertens Rep; 2008 Jun; 10(3):222-6. PubMed ID: 18765094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
